Renal Failure

  • Lipoprotein abnormalities in the progression of renal disease
    Michael D. Cressman, DO, Kimberly C. Irwin, MD and Nicholas T. Stowe, PhD
    Cleveland Clinic Journal of Medicine October 1990, 57 (7) 599-604;

    Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.